基本信息
浏览量:118
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
A member of Pfizer’s Worldwide Research, Development, and Medical leadership team, Dr. Jansen leads a fully integrated, global vaccines research and development organization. Her responsibilities range from discovery to registration and post-marketing commitments and a clinical vaccines portfolio that includes vaccines to prevent or treat diseases of significant unmet medical need. These include Streptococcus pneumonia, Clostridium difficile, Respiratory syncytial virus, Group B streptococcus and prostate cancer. Dr. Jansen’s recent accomplishments are the global licensures of Prev(e)nar13® to prevent pneumococcal diseases and the development and licensure of Trumenba®, the first vaccine licensed in the United States to prevent invasive disease caused by Neisseria meningitidis serogroup B.
研究兴趣
论文共 340 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature Communicationsno. 1 (2024): 1-21
JOURNAL OF INFECTIOUS DISEASESno. 2 (2024): 367-375
The journal of infectious diseases (Online University of Chicago Press)/The Journal of infectious diseases (2024)
Clinical infectious diseases/Clinical infectious diseases (Online University of Chicago Press)no. 2 (2023): 312-320
Elsevier eBookspp.1374-1396.e11, (2023)
引用0浏览0引用
0
0
B. Kampmann,S. A. Madhi,I. Munjal,E. A. F. Simoes, B. A. Pahud, C. Llapur, J. Baker,G. Perez Marc, D. Radley, E. Shittu, J. Glanternik, H. Snaggs,
The New England journal of medicineno. 7 (2023): 621-634
Francis Collins,Stacey Adam, Christine Colvis, Elizabeth Desrosiers,Ruxandra Draghia-Akli,Anthony Fauci,Maria Freire,Gary Gibbons,Matthew Hall, Eric Hughes,Kathrin Jansen,Michael Kurilla,
加载更多
作者统计
#Papers: 319
#Citation: 34870
H-Index: 74
G-Index: 183
Sociability: 8
Diversity: 3
Activity: 267
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn